Changqing Su

Prof. Changqing Su

National Center for Liver Cancer of China
orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Theranostics
Verified
Journal Article
Open access
CLChunying Liu
Chunying Liu
CSChangqing Su
Changqing Su
Exosomes have great potential to be drug delivery vehicles due to their natural material transportation properties, intrinsic long-term circulatory capability, and excellent biocompatibility, which are suitable for delivering a variety of chemicals, proteins, nucleic acids, and gene therapeutic agents. However, an effective method of loading specific protein agents into exosomes for absorption by target cells is still lacking. The application potential of exosome is still limited. In this review, we discussed the methods for loading specific treating molecules (proteins, nucleic acids and small chemicals) into exosomes, the design strategies for cell and tissue targeting, and the factors for exosome formation. This review can be used as a reference for further research as well as for the development of therapeutic exosomes.

14 February 2014 in Tumor Biology
Verified
Journal Article
Closed access
PDF file
YLYan Liu
Yan Liu
YXYang Xu
Yang Xu
WJWeidan Ji
Weidan Ji
XLXiaoya Li
Xiaoya Li
BSBin Sun
Bin Sun
CSChangqing Su
Changqing Su

1 January 2021 in Cancer Letters
Verified
Journal Article
Closed access
ZPZhang-Xiao Peng
Zhang-Xiao Peng
YCYanxin Chang
Yanxin Chang
JFJianhui Fan
Jianhui Fan
WJWeidan Ji
Weidan Ji
CSChangqing Su
Changqing Su

9 January 2017 in Genes
Verified
Journal Article
Open access
PDF file
WJWeidan Ji
Weidan Ji
BSBin Sun
Bin Sun
CSChangqing Su
Changqing Su
MicroRNAs (miRNAs) are a kind of conserved small non-coding RNAs that participate in regulating gene expression by targeting multiple molecules. Early studies have shown that the expression of miRNAs changes significantly in different tumor tissues and cancer cell lines. It is well acknowledged that such variation is involved in almost all biological processes, including cell proliferation, mobility, survival and differentiation. Increasing experimental data indicate that miRNA dysregulation is a biomarker of several pathological conditions including cancer, and that miRNA can exert a causal role, as oncogenes or tumor suppressor genes, in different steps of the tumorigenic process. Anticancer therapies based on miRNAs are currently being developed with a goal to improve outcomes of cancer treatment. In our present study, we review the function of miRNAs in tumorigenesis and development, and discuss the latest clinical applications and strategies of therapy targeting miRNAs in cancer.

Verified
Journal Article
Open access
PDF file
XLXuejing Lin
Xuejing Lin
ZPZhang-Xiao Peng
Zhang-Xiao Peng
CSChangqing Su
Changqing Su
Costunolide (CE) and dehydrocostuslactone (DE) are derived from many species of medicinal plants, such as Saussurea lappa Decne and Laurus nobilis L. They have been reported for their wide spectrum of biological effects, including anti-inflammatory, anticancer, antiviral, antimicrobial, antifungal, antioxidant, antidiabetic, antiulcer, and anthelmintic activities. In recent years, they have caused extensive interest in researchers due to their potential anti-cancer activities for various types of cancer, and their anti-cancer mechanisms, including causing cell cycle arrest, inducing apoptosis and differentiation, promoting the aggregation of microtubule protein, inhibiting the activity of telomerase, inhibiting metastasis and invasion, reversing multidrug resistance, restraining angiogenesis has been studied. This review will summarize anti-cancer activities and associated molecular mechanisms of these two compounds for the purpose of promoting their research and application.

1 September 2016 in Cancer Letters
Verified
Journal Article
Closed access
CSChangqing Su
Changqing Su